Selecting the Best Proton Therapy Specialists and Hospitals in India: A Guide for Patients from Iraq

Author:- Dr. Dheeraj Bojwani Date Created:- 23-07-2026

Over the years, I have found that proton therapy is one of the treatments most often oversold in general marketing language, presented as simply “safer radiation” for every cancer type, when the honest evidence is considerably more specific: proton therapy shows genuine, measurable benefit for certain tumour types and age groups, while for others the evidence remains less definitive, and a family deserves to know which category their specific situation falls into.

Healing Journeys of Iraqi Patients

Iraqi Patients Share Their Experience

Why the Choice of Proton Therapy Centre in India Matters as Much as the Choice of Technology

Based on my interactions with international families, the published evidence on this exact distinction is genuinely informative. A systematic review and meta-analysis of pediatric intracranial ependymoma, a specific type of childhood brain tumour, found five-year overall survival of 84.7 percent with proton beam therapy compared with 73.8 percent using conventional photon radiotherapy, alongside meaningfully better local tumour control, a real and clinically significant advantage for this specific tumour type. For adolescents and young adults with early-stage Hodgkin lymphoma, a separate study found two-year progression-free survival of 94 percent with proton therapy compared with 83 percent with photon therapy, though this particular difference did not reach statistical significance given the study’s size, illustrating that a promising trend is not always the same as proven superiority. The American National Cancer Institute has specifically noted that no randomised clinical trials comparing proton and photon therapy have yet been conducted in children, and that the true magnitude of any reduction in long-term second cancer risk, one of proton therapy’s most often cited advantages, remains genuinely uncertain. India is notably one of only a small number of middle-income countries, alongside China and Thailand, to have proton therapy centres already operating domestically, a genuine achievement, though this also means the number of centres with deep, specific experience remains limited nationally. This tells a family something important: ask specifically what evidence exists for your child’s exact tumour type, rather than accepting a general claim that proton therapy is simply the safer choice for every situation.

How Patients from Iraq Can Verify a Proton Therapy Hospital’s Accreditation in India

The fastest filter I recommend to every Iraqi family calling about proton therapy is verifiable accreditation, not marketing language. Joint Commission International, JCI, audits a hospital’s overall clinical safety systems against the same standard used across the United States and Europe. The National Accreditation Board for Hospitals and Healthcare Providers, NABH, is India’s own domestic equivalent, and in my experience of 24 years advising families on this exact decision, a centre holding both marks together is a meaningfully stronger signal than either alone. For proton therapy specifically, ask one further, very direct question: what is this centre’s own specific experience and outcome data for your child’s exact tumour type, since the evidence base for proton therapy’s benefit varies considerably by diagnosis.

Proton Therapy Volume and Tumour-Specific Criteria That Predict Outcomes in India

Based on my interactions with dozens of radiation oncology programmes over the years, a centre’s specific experience with your exact tumour type, not simply its general proton therapy capability, is one of the clearest signs of a trustworthy, evidence-based recommendation. In my experience of 24 years advising families on this exact decision, the centres most worth trusting are the ones willing to say honestly when photon radiotherapy is an equally reasonable option for a specific tumour type. Ask directly, in writing:

1. What is the specific published or centre-reported evidence supporting proton therapy over conventional photon radiotherapy for my child's exact tumour type and location?
2. How many patients with this specific tumour type has this centre treated using proton therapy, and what are their own reported outcomes?
3. For tumours where the evidence is less definitive, has the centre discussed photon radiotherapy as a genuinely equivalent alternative, or is proton therapy being recommended regardless of the specific evidence for this tumour type?
4. What is the centre's specific plan for monitoring long-term side effects, particularly for a child whose developing body will be followed for decades after treatment?

A centre confident in its own reasoning will answer these specifically and honestly, including acknowledging where evidence is still developing. A centre that presents proton therapy as unconditionally superior for every cancer type deserves a second opinion before you commit.

Vetting a Proton Therapy Hospital in India: A Guide for Patients from Iraq

Questions Patients from Iraq Should Ask About the Proton Therapy Team in India

Proton therapy planning and delivery are never genuinely the work of one specialist alone. In my experience of 24 years watching these programmes operate, the strongest units bring together a radiation oncologist with specific proton therapy experience, a medical physicist for the highly precise dose planning this technology requires, and, for paediatric cases, a paediatric oncologist involved in the overall treatment strategy. A dedicated paediatric anaesthesiologist is a further important role for young children, since achieving the precise, motionless positioning proton therapy requires often means sedation or anaesthesia is needed for each individual treatment session over several weeks. Ask specifically who fills each of these roles for your case, and confirm that your specific tumour type and its evidence base have been discussed openly before treatment begins.

Proton Therapy Technology Standards in India That Patients from Iraq Should Check

The specific technology available changes what precision a centre can achieve. Ask whether the centre uses pencil beam scanning, a more precise proton delivery technique than older passive scattering methods, since this technology allows more targeted dose delivery and potentially better sparing of healthy tissue. Ask what specific imaging and immobilisation technology is used to ensure the child remains precisely positioned for each treatment session, since proton therapy’s precision advantage depends entirely on accurate, consistent positioning. Ask also whether the centre performs regular quality assurance imaging throughout the multi-week treatment course to confirm the tumour and surrounding anatomy have not shifted in ways that would require the treatment plan to be adjusted. Ask directly which of these specific capabilities apply to your case, not simply whether the hospital owns proton therapy equipment in general terms.

Red Flags Patients from Iraq Should Watch For When Choosing a Proton Therapy Hospital in India

Over the years, certain patterns have become reliable warning signs for me. A centre that recommends proton therapy for every cancer type without discussing the specific evidence for your child’s exact tumour has not given you an honest, evidence-based recommendation. A centre that cannot state its own specific experience and outcomes for your child’s exact diagnosis has not demonstrated the specialised expertise this technology requires. A centre that does not discuss photon radiotherapy as a genuine alternative where evidence supports comparable outcomes is not presenting the complete picture of your child’s treatment options. And a centre that overstates the certainty of long-term benefits, such as reduced second cancer risk, without acknowledging that this evidence is still developing in children specifically, is not giving your family an honest picture of current knowledge.

Factors Every Family from Iraq Should Weigh Before Choosing Proton Therapy in India

A Closing Thought for Iraqi Families

Proton therapy is a genuinely valuable technology for specific tumour types and situations, and it deserves a treatment team that explains honestly which category your child’s diagnosis falls into, rather than a general claim that it is simply the safer choice for every cancer. Based on my interactions with international patients over more than two decades, the families who ask about tumour-specific evidence, centre experience, and honest comparison with photon radiotherapy consistently arrive at treatment better informed than those who accept a general marketing claim at face value. My role, and the role of any advisor a family works with, should be to help you ask these exact questions and confirm honestly that the specific team and specific hospital in front of you are the right fit for your family’s exact diagnosis. Iraq’s families deserve the same standard of scrutiny in this decision as any family anywhere else in the world.

Sources & Further Reading

• Joint Commission International (JCI) — Accredited Organizations Directory (jointcommissioninternational.org)
• National Accreditation Board for Hospitals & Healthcare Providers (NABH), India (nabh.co)
• PMC — Systematic Review and Meta-Analysis of Photon Radiotherapy vs. Proton Beam Therapy for Pediatric Intracranial Ependymoma (ncbi.nlm.nih.gov/pmc)
• PMC — Comparative Effectiveness of Proton Therapy vs. Photon Radiotherapy in AYAs for Classical Hodgkin Lymphoma (ncbi.nlm.nih.gov/pmc)
• National Cancer Institute (NCI) — Pediatric Proton and Photon Therapy Comparison Cohort (dceg.cancer.gov)

Frequently Asked Questions by Iraqi Patients about Selecting a Proton Therapy Specialist and Hospital in India